SCHEMBL22010811

SCHEMBL22010811

CCCCCc1cc2oc3cc(OCC)c(F)c(F)c3c2c(F)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.36
NOD2 Q9HC29 1/20 0.36
ALDH1A1 P00352 7/20 0.34
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
GAA P10253 5/20 0.34
HTT P42858 4/20 0.34
HPGD P15428 4/20 0.34
MAPT P10636 3/20 0.34
GLA P06280 2/20 0.34
POLB P06746 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 2/20 0.34
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
HIF1A Q16665 1/20 0.33
LMNA P02545 1/20 0.33
ATM Q13315 1/20 0.33
ALOX5 P09917 5/20 0.33
PGAM1 P18669 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010964 0.96 KDM4E (0.37) KDM4ENOD2ALDH1A1MEN1KMT2A
SCHEMBL22011226 0.90 HMGCR (0.36) KDM4EALDH1A1HTTHPGDMAPT
SCHEMBL22011793 0.89 ALOX5 (0.41) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL22010799 0.88 PGAM1 (0.39) KDM4EALDH1A1HPGDHSD17B10PGAM1
SCHEMBL22011802 0.87 CTSL (0.38) KDM4ENOD2ALDH1A1MEN1KMT2A
SCHEMBL22010796 0.86 L3MBTL1 (0.35) ALDH1A1GAAMAPTNPSR1PGAM1
SCHEMBL22011095 0.86 PGAM1 (0.38) KDM4EALDH1A1HTTHPGDHSD17B10
SCHEMBL22010968 0.85 PGAM1 (0.42) PGAM1
SCHEMBL22011800 0.85 HTT (0.37) KDM4ENOD2ALDH1A1MEN1KMT2A
SCHEMBL22011788 0.84 PGAM1 (0.42) KDM4EALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 KDM4E 2962/4885NOD2 1297/4885ALDH1A1 577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.